Search - tctmd.com

Displaying 161 - 180 of 465

Sort: Relevancy | Date

Presentation TCT 2018

Choosing the Right TAVR for Your Patient

Presenter: Howard C. Herrmann

September 22, 2018

Presentation TCT 2018

The Repositionable and Retrievable HLT Meridian TAVR System

Presenter: Mathew Williams

September 22, 2018

Presentation TCT 2018

The Venus A-Valve and Venibri TAVR Systems

Presenter: Horst Sievert

September 22, 2018

Presentation TCT 2018

The Anatomically Correct JenaValve TAVR System

Presenter: Hendrik Treede

September 22, 2018

Presentation TCT 2018

The Self-Expanding Single-Operators CENTERA TAVR System

Presenter: Ulrich Schäfer

September 22, 2018

Presentation TCT 2018

Program Update: The PORTICO TAVR System

Presenter: Gregory P. Fontana

September 22, 2018

Presentation TCT 2018

Program Update: The ACURATE NEO TAVR System

Presenter: Alexandre Abizaid

September 22, 2018

Presentation TCT 2018

Program Update: The LOTUS TAVR System

Presenter: Michael J. Reardon

September 22, 2018

Presentation TCT 2018

Opinion Patient Preferences and Shared Decision-Making Requires Open Access to Both TAVR and SAVR

Presenter: Megan Coylewright

September 22, 2018

Presentation TCT 2018

Counterpoint SAVR Is the Gold Standard and Deserves Priority Treatment!

Presenter: Alfredo Trento

September 22, 2018

Presentation TCT 2018

Point Parity Should Include Valve Assessments, Regulatory Standards, and Equal Patient Access

Presenter: Michael J. Mack

September 22, 2018

Presentation TCT 2018

Opinion Tiered Systems of Care Are Preferred to Optimize Patient Care In Valvular Heart Disease

Presenter: Patrick T. O'Gara

September 22, 2018

Presentation TCT 2018

Counterpoint Volume Thresholds Distort Clinical Practice, Quality Metrics are the Priority and Have a Greater Impact on Outcomes

Presenter: Martin B. Leon

September 22, 2018

Presentation TCT 2018

Point Volume Threshold Increases are Needed to Assess Quality and Improve Clinical Outcomes

Presenter: Joseph E. Bavaria

September 22, 2018

Presentation TCT 2018

Opinion Concerns of TAVR Access for Underserved Populations

Presenter: Aaron Horne, Jr.

September 22, 2018

Presentation TCT 2018

Counterpoint Current and Future Demands Will Require TAVR Site Expansion

Presenter: Mark J. Russo

September 22, 2018

Presentation TCT 2018

Point Access Considerations Can be Managed Without Significant TAVR Site Expansion

Presenter: Carl L. Tommaso

September 22, 2018

Presentation TCT 2018

Case #8: An Iatrogenic ASD During Transcatheter Mitral Valve Repair: When and Why to Close

Presenter: Hüseyin Ince, Matthew J. Price, Anita Asgar, Eric A. Cohen, Oscar A. Mendiz, Frederick G. St. Goar, Corrado Tamburino, Brian K. Whisenant

September 22, 2018

Presentation TCT 2018

Case #4: Transcatheter MitraClip Repair for Commissural Regurgitation

Presenter: Hüseyin Ince, Matthew J. Price, Anita Asgar, Eric A. Cohen, Oscar A. Mendiz, Frederick G. St. Goar, Corrado Tamburino, Brian K. Whisenant

September 22, 2018

Presentation TCT 2018

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presenter: Michael J. Mack, Bernard Prendergast, George D. Dangas

September 22, 2018

Advertisement

Choosing the Right TAVR for Your Patient

The Repositionable and Retrievable HLT Meridian TAVR System

The Venus A-Valve and Venibri TAVR Systems

The Anatomically Correct JenaValve TAVR System

The Self-Expanding Single-Operators CENTERA TAVR System

Program Update: The PORTICO TAVR System

Program Update: The ACURATE NEO TAVR System

Program Update: The LOTUS TAVR System

Opinion Patient Preferences and Shared Decision-Making Requires Open Access to Both TAVR and SAVR

Counterpoint SAVR Is the Gold Standard and Deserves Priority Treatment!

Point Parity Should Include Valve Assessments, Regulatory Standards, and Equal Patient Access

Opinion Tiered Systems of Care Are Preferred to Optimize Patient Care In Valvular Heart Disease

Counterpoint Volume Thresholds Distort Clinical Practice, Quality Metrics are the Priority and Have a Greater Impact on Outcomes

Point Volume Threshold Increases are Needed to Assess Quality and Improve Clinical Outcomes

Opinion Concerns of TAVR Access for Underserved Populations

Counterpoint Current and Future Demands Will Require TAVR Site Expansion

Point Access Considerations Can be Managed Without Significant TAVR Site Expansion

Case #8: An Iatrogenic ASD During Transcatheter Mitral Valve Repair: When and Why to Close

Case #4: Transcatheter MitraClip Repair for Commissural Regurgitation

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content